ArticleWorld journal of oncology2025

Co-expression of HER2/EGFRvIII/CD44 and Claudin 18.2/CD109 as Novel Prognostic Indicators in Stomach Adenocarcinoma.

Tina Al Janaby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.